[http://dx.doi.org/10.1111/j.1469-0691.2005.01082]
[http://dx.doi.org/10.1093/infdis/jix326]
[http://dx.doi.org/10.1111/1469-0691.1275]
Infectious Disorders - Drug Targets
Title:COVID-19 and Infectious Disease Speciality - A Necessity of Time in India
Volume: 22 Issue: 2
Author(s): Gopal K. Bohra, Deepak Kumar*Mahendra K. Garg
Affiliation:
- Department of Medicine, All India Institute of Medical Sciences Jodhpur, India
Export Options
About this article
Cite this article as:
Bohra K. Gopal, Kumar Deepak*, Garg K. Mahendra, COVID-19 and Infectious Disease Speciality - A Necessity of Time in India, Infectious Disorders - Drug Targets 2022; 22 (2) : e170322191976 . https://dx.doi.org/10.2174/1871526521666210302155650
DOI https://dx.doi.org/10.2174/1871526521666210302155650 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Developments In Treatment After Lung Transplantation
Current Pharmaceutical Design Withdrawal Notice: An Efficient Approach for Detection and Verification of Infected Cases of Covid-19 Virus through Block Chain: A Survey
International Journal of Sensors, Wireless Communications and Control The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review
Current Medicinal Chemistry Physical and Mental Functions of Cardiovascular Diseased Patients Decrease During the State of Emergency Initiated by the COVID-19 Pandemic in Japan
Reviews on Recent Clinical Trials Preventive and Therapeutic Strategies to Fight COVID-19
Current Pharmaceutical Design Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science The Compound 6-Chloro-1,4-Dihydro-4-Oxo-1-(β-D-Ribofuranosyl) Quinoline-3-Carboxylic Acid Inhibits HIV-1 Replication by Targeting the Enzyme Reverse Transcriptase
Current HIV Research Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
Coronaviruses Molecular Recognition of Human Angiotensin-Coverting Enzyme I (hACE I) and Different Inhibitors
Current Topics in Medicinal Chemistry Forecasting of Covid-19 Cases Using Machine Learning Approach
Current Respiratory Medicine Reviews The Effect of Plant Metabolites on Coronaviruses: A Comprehensive Review Focusing on their IC<sub>50</sub> Values and Molecular Docking Scores
Mini-Reviews in Medicinal Chemistry Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options
Current Topics in Medicinal Chemistry Epidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis
Reviews on Recent Clinical Trials An Overall Picture of SARS Coronavirus (SARS-CoV) Genome-Encoded Major Proteins: Structures, Functions and Drug Development
Current Pharmaceutical Design Protein Structure Prediction in Structure-Based Ligand Design and Virtual Screening
Combinatorial Chemistry & High Throughput Screening An Update on the Bananins: Anti-RNA-Viral Agents with Unique Structural Signature
Anti-Infective Agents <i>Nigella Sativa</i>: An Immunity Booster as Pandemic Treatment Solution Against SARS-CoV-2
Coronaviruses Anticipating a Post COVID-19 World and the Pivotal Role of Science and Technology
Coronaviruses Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review
Coronaviruses